spacer
spacer

PDBsum entry 4zak

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
4zak

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
267 a.a.
98 a.a.
203 a.a.
239 a.a.
Ligands
NAG-NAG
NAG ×2
4LX
PDB id:
4zak
Name: Immune system
Title: Crystal structure of the mcd1d/db06-1/inktcr ternary complex
Structure: Antigen-presenting glycoprotein cd1d1. Chain: a. Engineered: yes. Beta-2-microglobulin. Chain: b. Engineered: yes. Protein trav11,va14ja18/vb8.2,human nkt tcr alpha chain. Chain: c. Synonym: protein trav11d,human nkt tcr beta chain.
Source: Mus musculus. Mouse. Organism_taxid: 10090. Gene: cd1d1, cd1.1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: b2m. Mus musculus, homo sapiens. Mouse, human.
Resolution:
2.82Å     R-factor:   0.218     R-free:   0.256
Authors: D.M.Zajonc,A.M.Birkholz
Key ref: A.M.Birkholz et al. (2015). A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production. J Immunol, 195, 924-933. PubMed id: 26078271 DOI: 10.4049/jimmunol.1500070
Date:
13-Apr-15     Release date:   01-Jul-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P11609  (CD1D1_MOUSE) -  Antigen-presenting glycoprotein CD1d1 from Mus musculus
Seq:
Struc:
336 a.a.
267 a.a.
Protein chain
Pfam   ArchSchema ?
P01887  (B2MG_MOUSE) -  Beta-2-microglobulin from Mus musculus
Seq:
Struc:
119 a.a.
98 a.a.
Protein chain
Pfam   ArchSchema ?
A0A0B4J1J9  (A0A0B4J1J9_MOUSE) -  T cell receptor alpha variable 11 (Fragment) from Mus musculus
Seq:
Struc:
114 a.a.
203 a.a.
Protein chain
A0A0G2JG46  (A0A0G2JG46_MOUSE) -  T cell receptor alpha joining 18 (Fragment) from Mus musculus
Seq:
Struc:
22 a.a.
203 a.a.*
Protein chain
Pfam   ArchSchema ?
K7N5M3  (K7N5M3_HUMAN) -  Human nkt tcr alpha chain from Homo sapiens
Seq:
Struc:
220 a.a.
203 a.a.*
Protein chain
Pfam   ArchSchema ?
A0A5B9  (TRBC2_HUMAN) -  T cell receptor beta constant 2 from Homo sapiens
Seq:
Struc:
178 a.a.
239 a.a.*
Protein chain
Pfam   ArchSchema ?
A0N8J3  (A0N8J3_MOUSE) -  Tcell receptor chain (Fragment) from Mus musculus
Seq:
Struc:
281 a.a.
239 a.a.*
Protein chain
Pfam   ArchSchema ?
A2NTY6  (A2NTY6_MOUSE) -  Beta-chain (Fragment) from Mus musculus
Seq:
Struc:
144 a.a.
239 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 172 residue positions (black crosses)

 

 
DOI no: 10.4049/jimmunol.1500070 J Immunol 195:924-933 (2015)
PubMed id: 26078271  
 
 
A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
A.M.Birkholz, E.Girardi, G.Wingender, A.Khurana, J.Wang, M.Zhao, S.Zahner, P.A.Illarionov, X.Wen, M.Li, W.Yuan, S.A.Porcelli, G.S.Besra, D.M.Zajonc, M.Kronenberg.
 
  ABSTRACT  
 
In this article, we characterize a novel Ag for invariant NKT (iNKT) cells capable of producing an especially robust Th1 response. This glycosphingolipid, DB06-1, is similar in chemical structure to the well-studied α-galactosylceramide (αGalCer), with the only change being a single atom: the substitution of a carbonyl oxygen with a sulfur atom. Although DB06-1 is not a more effective Ag in vitro, the small chemical change has a marked impact on the ability of this lipid Ag to stimulate iNKT cells in vivo, with increased IFN-γ production at 24 h compared with αGalCer, increased IL-12, and increased activation of NK cells to produce IFN-γ. These changes are correlated with an enhanced ability of DB06-1 to load in the CD1d molecules expressed by dendritic cells in vivo. Moreover, structural studies suggest a tighter fit into the CD1d binding groove by DB06-1 compared with αGalCer. Surprisingly, when iNKT cells previously exposed to DB06-1 are restimulated weeks later, they have greatly increased IL-10 production. Therefore, our data are consistent with a model whereby augmented and or prolonged presentation of a glycolipid Ag leads to increased activation of NK cells and a Th1-skewed immune response, which may result, in part, from enhanced loading into CD1d. Furthermore, our data suggest that strong antigenic stimulation in vivo may lead to the expansion of IL-10-producing iNKT cells, which could counteract the benefits of increased early IFN-γ production.
 

 

spacer

spacer